Pro-Adrenomedullin predicts 10-year all-cause mortality in community-dwelling patients: a prospective cohort study.
Jonas OdermattMarc MeiliLara HersbergerRebekka BolligerMirjam Christ-CrainMatthias BrielHeiner C BucherBeat MuellerPhilipp SchuetzPublished in: BMC cardiovascular disorders (2017)
Current Controlled Trials, SRCTN73182671.